GREENWOOD, SC – Greenwood Diagnostic Laboratories at the Greenwood Genetic Center, in collaboration with London Health Sciences Centre (LHSC), announce the launch of a new diagnostic test focused on disease-specific epigenetic signatures. The test, EpiSign, which is performed on a peripheral blood sample, analyzes DNA methylation patterns of the genome to establish a diagnosis or help resolve variants of uncertain significance (VUS) found through DNA testing. To date, combined efforts have identified unique methylation patterns, known as epigenetic signatures, for 19 genetic disorders including CHARGE syndrome, Cornelia de Lange syndrome, DownSEE DETAILS <span c...
GREENVILLE, SC – The Greenwood Genetic Center (GGC) is pleased to announce it has been selected as one of approximately 20 sites in the United States, Australia, and New Zealand now enrolling patients in a clinical trial for Fragile X syndrome (FXS). The study will include more than 200 male and female individuals ages three through 17. FXS is a genetic condition that causes intellectual disability, behavioral and learning challenges, and is also the most common known single gene cause of autism spectrum disorder. The newly-initiated study, CONNECT-FX (Clinical Study of CannabidiolSEE DETAILS
GREENWOOD, SC – The Greenwood Genetic Center’s (GGC’s) new Director of Research, Richard Steet, PhD, is bringing big changes to the Center. Steet, who joined GGC in August from the University of Georgia, and his longtime collaborator, Heather Flanagan-Steet, PhD, have developed an aquaculture facility at the Center for the study of zebrafish, a model organism for human genetic disorders.And now Steet has successfully renewed a National Institutes of Health R01 grant from the National Institute of General Medical Sciences which will bring $1.2 million dollars to the Center’s Division of Research overSEE DETAILS
GREENWOOD, South Carolina – Trudy Mackay and Robert Anholt of Clemson University’s Center for Human Genetics in Greenwood have received $1.87 million from the National Institutes of Health to advance research aimed at significantly increasing our fundamental understanding of the complex roles molecular variations play in human disease.Human beings share 99.9 percent of all DNA (the carrier of genetic information), but the 0.1 percent that isn’t shared is what makes each person unique. Everyone’s genome (an organism’s complete set of DNA) contains millions of genetic variants that affect everything fromSEE DETAILS